On the basis of these clinical observations, we then systematically examined our AHO mouse model generated through the targeted disruption of Gnas exon 1 (Gnas E1+/-) [22, 26, 68] to evaluate how Gnas heterozygous inactivation influences craniofacial development and bone formation. Here, GNAS is linked to pseudohypoparathyroidism type 1A.